Cargando…
Enhancing glucose metabolism via gluconeogenesis is therapeutic in a zebrafish model of Dravet syndrome
Energy-producing pathways are novel therapeutic targets for the treatment of neurodevelopmental disorders. Here, we focussed on correcting metabolic defects in a catastrophic paediatric epilepsy, Dravet syndrome which is caused by mutations in sodium channel NaV1.1 gene, SCN1A. We utilized a transla...
Autores principales: | Banerji, Rajeswari, Huynh, Christopher, Figueroa, Francisco, Dinday, Matthew T, Baraban, Scott C, Patel, Manisha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023476/ https://www.ncbi.nlm.nih.gov/pubmed/33842883 http://dx.doi.org/10.1093/braincomms/fcab004 |
Ejemplares similares
-
Altered Glycolysis and Mitochondrial Respiration in a Zebrafish Model of Dravet Syndrome123
por: Kumar, Maneesh G., et al.
Publicado: (2016) -
Large-Scale Phenotype-Based Antiepileptic Drug Screening in a Zebrafish Model of Dravet Syndrome1,2,3
por: Dinday, Matthew T., et al.
Publicado: (2015) -
Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet Syndrome treatment
por: Baraban, Scott C., et al.
Publicado: (2013) -
Phenotype-Based Screening of Synthetic Cannabinoids in a Dravet Syndrome Zebrafish Model
por: Griffin, Aliesha, et al.
Publicado: (2020) -
Behavioral Comorbidities and Drug Treatments in a Zebrafish scn1lab Model of Dravet Syndrome
por: Grone, Brian P., et al.
Publicado: (2017)